Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Vaxart Inc
VXRT
Healthcare
Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its...
development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:VXRT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 30, 2024 5:00pm
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b
Breaking News: $VXRT Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate@ 400 subject sentinel portion of Phase 2b study will evaluate
...more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 01, 2024 6:08pm
Vaxart, Inc. (NASDAQ:VXRT) – Oral Vaccine Platform Off
https://beyondspx.com/2024/08/01/vaxart-inc-nasdaqvxrt-oral-vaccine-platform-offers-promising-path-to-address-major-public-health-challenges/
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Jun 13, 2024 8:06pm
BUY BUY BUY BUY BUY
After market 1..20/share it s gonna rock
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Jun 13, 2024 8:05pm
BUY BUY BUY BUY BUY
After market 1..20/share it s gonna rock
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jan 19, 2024 9:25am
Good news
$9.27 Million Barda Grant
(1)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Sep 09, 2022 3:21pm
Oral Vaccine news
Once again VXRT gets no respect
(0)
•••
Vaxartbzdv
X
View Profile
View Bullboard History
Post by
Vaxartbzdv
on Jan 27, 2022 9:59pm
Vaxart petition to improve IR/PR
Hi all. Just sharing a petition that is circulating online; asking Vaxart to improve its IR/PR representation. https://chng.it/QHTshgNBpb
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on May 04, 2021 7:59am
VXRT......on watch
Been a high volume trader recently No chasing
(47)
•••
ITSUP2ME
X
View Profile
View Bullboard History
Post by
ITSUP2ME
on Mar 16, 2021 7:59am
Mirror image of things to come...
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet
...more
(0)
•••
thevisionary2k
X
View Profile
View Bullboard History
Post by
thevisionary2k
on Feb 12, 2021 8:32am
VXRT - Institutional Investors
Let’s put into perspective the VXRT-State Street, BlackRock and Vanguard investments - three (3) of largest asset management and investment firms in the world with $18 Trillion in Assets.
...more
(0)
•••
thevisionary2k
X
View Profile
View Bullboard History
Post by
thevisionary2k
on Feb 11, 2021 9:31am
VXRT - StockInvest US
This morning StockInvest US released a VXRT stock and trend analysis, which included the following: “Given the current short-term trend, the stock is expected to rise 22.78% during the next
...more
(0)
•••
thevisionary2k
X
View Profile
View Bullboard History
Post by
thevisionary2k
on Feb 11, 2021 9:14am
VXRT - BlackRock and Vanguard
BlackRock, the world's largest asset manager, with $8.67 trillion in assets under management as of January 2021, increased its VXRT position to 4.9 million shares as of 12/31/20, a jump of 645
...more
(0)
•••
thevisionary2k
X
View Profile
View Bullboard History
Post by
thevisionary2k
on Feb 10, 2021 5:11am
VXRT Rise in Stock Price
On February 2, 2021 and February 3, 2021, the New York Academy of Sciences held a global Symposium, “The Quest for a Covid-19 Vaccine.” Dr. Antony Fauci, National Institute of Infectious
...more
(8)
•••
Dalahlama
X
View Profile
View Bullboard History
Post by
Dalahlama
on Feb 08, 2021 11:10pm
Up 23% in one day
And it's just a start. This next wave will continue to rise at least the next week and looks like a promising long term medical investment to add to your portfolio.
(38)
•••
bligicka
X
View Profile
View Bullboard History
Comment by
bligicka
on Feb 04, 2021 10:51pm
RE:"antivax"?
I really like Vaxil's odds now that Vaxart is out of the running !!!
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >